Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04504773 · ClinicalTrials.gov registry record · NA
Using Immersive Virtual Reality to Treat Pediatric Anxiety
A NA study of Specific Phobia and Specific Phobia, Animal, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT04504773 is a NA study of Specific Phobia and Specific Phobia, Animal that has completed, run by Johns Hopkins University. The registered enrollment target is 3 participants, below the 201-participant average among 5 other Specific Phobia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04504773, a NA study of Specific Phobia and Specific Phobia, Animal, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Anxiety is a common and impairing problem for children. The principle treatment for pediatric anxiety involves facing a child's fears in a stepwise approach through a therapeutic exercise called exposures. While exposures are effective, some feared situations cannot be confronted in a clinician's office (e.g., heights, public speaking, storms). This poses a logistical challenge in treatment that: (1) takes time away from patient care, (2) leads clinicians to rely on imagined exposures, and/or (3) requires families to complete exposures outside of the therapy visits. This creates a burden for clinicians and families, and impedes treatment success. Immersive virtual reality (VR) presents an innovative solution that allows children to face fears without leaving the clinician's office. While VR has been used to distract children during painful medical procedures, it has not been well examined as a primary treatment for pediatric anxiety. This study proposes to examine the effectiveness and acceptability of using immersive VR exposures to treat children and adolescents with specific phobias.
Conditions Studied
Interventions
- BEHAVIORAL Virtual Reality Exposure Therapy
Study Locations (1)
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-09-17 |
| Est. Completion | 2023-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04504773
The ClinicalTrials.gov registry entry for NCT04504773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 5 other Specific Phobia trials with a reported enrollment target (99% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Specific Phobia appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality Exposure Therapy is the first listed.
NCT04504773 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04504773 about?
NCT04504773 is a clinical study titled "Using Immersive Virtual Reality to Treat Pediatric Anxiety". Anxiety is a common and impairing problem for children. The principle treatment for pediatric anxiety involves facing a child's fears in a stepwise approach through a therapeutic exercise called exposures. While exposures are effective, some feared situations cannot be confronted in a clinician's of...
What is the current status of trial NCT04504773?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2020-09-17. Estimated completion is 2023-02-14.
What conditions does trial NCT04504773 study?
This clinical trial studies the following conditions: Specific Phobia, Specific Phobia, Animal, Childhood Anxiety Disorder, Specific Phobia, Situational, Specific Phobia, Natural Environment.
What interventions are being tested in trial NCT04504773?
The interventions under investigation include: Virtual Reality Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04504773?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04504773 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Specific Phobia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stepped Care Treatment for Anxiety Resilience
RECRUITING · NA
-
Psychotherapy for Anxiety in Children With Autism Spectrum Disorder
COMPLETED · NA
-
Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics
COMPLETED · NA
-
Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders
COMPLETED · NA
-
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.